You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
2
Wishlist
0
Compare
0
Contacts

Casodex film-coated tablets 150 mg No. 28

SKU: an-18158
0
All about product
Description
Specification
Reviews 0
Questions0
new
Casodex film-coated tablets 150 mg No. 28
Casodex film-coated tablets 150 mg No. 28
Casodex film-coated tablets 150 mg No. 28
Casodex film-coated tablets 150 mg No. 28
In Stock
3 038.11 грн.
Buy this product in 1 click:
Active ingredient:Bicalutamide
Adults:Not intended for use by women
ATC code:L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; L02 AGENTS USED FOR HORMONE THERAPY; L02B HORMONE ANTAGONISTS AND ANALOGUES; L02B B Antiandrogenic agents; L02B B03 Bicalutamide
Country of manufacture:Great Britain
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Casodex film-coated tablets 150 mg No. 28
3 038.11 грн.
Description

Casodex tablets are indicated for monotherapy or as adjuvant therapy in combination with radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk of disease progression.

Composition

Active ingredient: bicalutamide;

1 film-coated tablet contains 150 mg of bicalutamide;

Excipients: lactose monohydrate, magnesium stearate, hypromellose; macrogol 300; povidone, sodium starch (type A); titanium dioxide (E 171).

Contraindication

Contraindicated for women and children.

It should not be prescribed to patients who have experienced hypersensitivity reactions to the active substance or any excipients included in the preparation.

Concomitant use of bicalutamide with terfenadine, astemizole, or cisapride is contraindicated.

Method of application

Adult men, including the elderly, one 150 mg tablet orally once a day.

The significant 150 mg dose must be taken for a long time, at least up to 2 years or until signs of disease progression appear.

Application features

Pregnant women

Contraindicated.

Children

Contraindicated.

Drivers

With caution.

Overdose

There are no data on overdose in humans. There is no specific antidote; treatment is symptomatic. Dialysis may be ineffective because bicalutamide is extensively protein bound and is not recovered unchanged in the urine. In case of overdose, general supportive care is indicated, including monitoring of vital signs.

Side effects

Blood and lymphatic system disorders. Anemia. Metabolic and nutritional disorders. Decreased appetite. Mental disorders. Decreased libido, depression. Nervous system disorders. Dizziness, drowsiness. Cardiac disorders. QT prolongation. Vascular disorders. Hot flashes. Digestive system disorders. Abdominal pain, constipation, dyspepsia, flatulence, nausea. Skin and subcutaneous tissue disorders. Rash, alopecia, hirsutism/hair regrowth, dry skin, itching. Renal and urinary disorders. Hematuria. Reproductive system and breast disorders. Gynecomastia and breast tenderness, erectile dysfunction. General disorders and administration site conditions. Asthenia, breast pain, edema.

Interaction

Caution should be exercised when prescribing bicalutamide with drugs that may inhibit the oxidation of the product (such as cimetidine, ketoconazole). Theoretically, this may lead to an increase in bicalutamide plasma concentrations and may lead to an increase in the side effects of the drug.

Due to the fact that antiandrogen therapy may lead to prolongation of the QT interval, caution should be exercised when prescribing bicalutamide concomitantly with drugs that can prolong the QT interval or cause the development of torsade de pointes, such as class IA (quinidine, disopyramide) or class III (amiodarone, sotalol, dofetilide, ibutilide) antiarrhythmic drugs, methadone, moxifloxacin, neuroleptics, etc.

Storage conditions

Store in the original packaging at a temperature not exceeding 30 °C.

Keep out of reach of children.

Shelf life - 4 years.

Specifications
Characteristics
Active ingredient
Bicalutamide
Adults
Not intended for use by women
ATC code
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; L02 AGENTS USED FOR HORMONE THERAPY; L02B HORMONE ANTAGONISTS AND ANALOGUES; L02B B Antiandrogenic agents; L02B B03 Bicalutamide
Country of manufacture
Great Britain
Diabetics
Can
Dosage
150 мг
Drivers
With caution, dizziness and drowsiness are possible.
For allergies
With caution
For children
It is impossible.
Form
Film-coated tablets
Method of application
Inside, solid
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
blister
Producer
AstraZeneca
Quantity per package
28 pcs
Trade name
Casodex
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Sold out
Neopax film-coated tablets 400 mg blister No. 60
Распродано
0
9 600.60 грн.
new
Eslotin film-coated tablets 5 mg No. 10
In stock
0
313.72 грн.
3 038.11 грн.